Fresenius Medical Care AG & Co. KGaA (FMEA STU) stock market data APIs
€22.1348
-0.12(-0.5%)
as of February 18, 2025
Fresenius Medical Care AG & Co. KGaA Financial Data Overview
Prev. Close
22.2552
Open
22.1348
High
22.2552
Low
22.1348
52 wk Range
16.1-23.8
Market Cap
15 704 M
Dividends (Yield)
0.0319
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Fresenius Medical Care AG & Co. KGaA data using free add-ons & libraries
Get Fresenius Medical Care AG & Co. KGaA Fundamental Data
Fresenius Medical Care AG & Co. KGaA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Fresenius Medical Care AG & Co. KGaA End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fresenius Medical Care AG & Co. KGaA News
New
Fresenius Medical price target raised to $25 from $23 at Truist
https://www.tipranks.com/news/the-fly/biocryst-price-target-raised-to-12-from-10-at-evercore-isi Truist raised the firm’s price target on Fresenius Medical (FMS) to $25 from $23 and keeps a Hold ra...
Fresenius Medical Care Profit Beats Market Views
The dialysis company stuck to its guidance for the year after profit soared ahead of analysts’ expectations. Continue reading View comments
Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024
A dedicated session will highlight new advancements in hemodiafiltration therapy showcasing its potential to improve patient outcomes through enhanced toxin removal in dialysis treatments. Company-wi...
Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last three years, but the stock advances 4.8% this past week
As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
